[HTML][HTML] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa… - Annals of oncology, 2014 - Elsevier
Background Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

[PDF][PDF] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee… - Annals of …, 2014 - researchgate.net
Background: Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

[引用][C] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee… - ANNALS OF …, 2014 - yscholarhub.yonsei.ac.kr
Background: Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

[PDF][PDF] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa… - Annals of …, 2014 - academia.edu
Background: Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee… - Annals of …, 2014 - yonsei.elsevierpure.com
Background: Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa… - Annals of …, 2014 - pure.au.dk
BACKGROUND: Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

DY Heng, TK Choueiri, BI Rini, J Lee… - Annals of Oncology …, 2014 - europepmc.org
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for
clinical trials. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

[PDF][PDF] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa… - Annals of …, 2014 - core.ac.uk
Background: Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini… - Annals of oncology …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Targeted therapies in metastatic renal cell carcinoma (mRCC) have been
approved based on registration clinical trials that have strict eligibility criteria. The clinical …

[引用][C] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa… - Annals of …, 2014 - cir.nii.ac.jp